⌘K

Login Start Free

Home/Filings/4/0001354488-16-008686

4//SEC Filing

TENAX THERAPEUTICS, INC. 4

Accession 0001354488-16-008686

$TENXCIK 0000034956operating

View on SEC.gov Company Profile

Filed

Dec 19, 7:00 PM ET

Accepted

Dec 20, 3:15 PM ET

Size

5.3 KB

Accession

0001354488-16-008686

Insider Transaction Report

Form 4

Period: 2016-12-15

TENAX THERAPEUTICS, INC.TENX

Jebsen Michael B

Chief Financial Officer

Transactions

Award
Stock Option (right to buy)
2016-12-15+150,000→ 150,000 total
Exercise: $2.07Exp: 2026-12-15→ Common Stock (150,000 underlying)

Footnotes (1)

[F1]This option vests and becomes exercisable in four equal annual installments beginning on December 15, 2017.

Documents

1 file

4
issuerdirect_section16.xmlPrimary
PRIMARY DOCUMENT

Issuer

TENAX THERAPEUTICS, INC.

CIK 0000034956

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0000034956

Filing Metadata

Form type: 4
Filed: Dec 19, 7:00 PM ET
Accepted: Dec 20, 3:15 PM ET
Size: 5.3 KB

View on SEC.gov